Effects of β-carotene and α-tocopherol on bleomycin-induced chromosomal damage

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 2, 1998, Pages 113-117

  Goodman, Marc T ^a   Hernandez, Brenda ^a   Wilkens, Lynne R ^a   Lee, James ^a   Le Marchand, Loïc ^a   Liu, Lucy Q ^a   Franke, Adrian A ^a   Küçük, Ömer ^b   Hsu, Tao C ^c  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL MARKER; BLEOMYCIN; CLASTOGEN; DNA; PLACEBO; TRACE ELEMENT;

ADULT; ARTICLE; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DNA DAMAGE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; MUTAGEN TESTING; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BETA CAROTENE; BLEOMYCIN; CHROMOSOME BREAKAGE; CROSS-OVER STUDIES; DIET; FEMALE; HUMANS; INTERVENTION STUDIES; LYMPHOCYTES; MALE; MUTAGENICITY TESTS; MUTAGENS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; VITAMIN E;

EID: 0031952134     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Olden, K. Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis. J. Natl. Cancer Inst , 86, 1660-1661, 1994.
2. Hsu, T. C Genetic instability in the human population: a working hypothesis Hereditas, 98 1-9, 1983.
3. Hsu, T C., Spitz, M. R , and Schantz, S. P. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol. Biomark Prev , 1: 83-89, 1991.
4. Spitz, M R., Hsu, T C., Wu, X F., Fueger, J. J., Amos, C I , and Roth, J. A. Mutagen sensitivity as a biologic marker of lung cancer in African Americans. Cancer Epidemiol. Biomark. Prev , 4: 99-103, 1995.
5. Spitz, M. R., Fueger, J. J , Halabi, S., Schantz, S. P., Sample, D., and Hsu, T C Mutagen sensitivity in upper aerodigestive tract cancer a case-control analysis. Cancer Epidemiol. Biomark. Prev., 2, 329-333, 1993.
6. Schantz, S. P., Spitz, M. R., and Hsu, T C. Mutagen sensitivity in head and neck cancer patients: a biological marker for risk of multiple primary malignancies. J Natl Cancer Inst, 82: 1773-1775, 1990.
7. Spitz, M. R., Hoque, A , Trizna, Z., Schantz, S. P , Amos, C. I., King, T. M., Bondy, M L., Hong, W. K , and Hsu, T. C. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J. Natl. Cancer Inst., 86: 1681-1684, 1994.
8. Küçuk, O., Pung, A, Franke, A. A., Custer, L. J., Wilkens, L. R., Le Marchand, L., Higuchi, C., Cooney, R. V., and Hsu, T. C. Correlations between mutagen sensitivity and plasma nutrient levels of healthy individuals. Cancer Epidemiol. Biomark Prev , 4, 217-221, 1995
9. Trizna, Z , Hsu, T. C., Schantz, S. P., Lee, J. J., and Hong, W. K. Anticlastogenic effects of 13-cis-retinoic acid in vitro. Eur. J. Cancer, 29A: 137-140, 1993.
10. Trizna, Z , Schantz, S. P., Lee, J. J , Spitz, M. R., Goepfert, H., Hsu, T. C., and Hong, W K. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detect. Prev., 17: 575-583, 1993
11. Pohl, H., and Reidy, J. Vitamin C intake influences the bleomycin-induced chromosome damage assay implications for detection of cancer susceptibility and chromosome breakage syndromes. Mutat. Res., 224, 247-252, 1989.
12. Cherry, L M , and Hsu, T C Bleomycin induced chromosome damage in lymphocytes of medullary lymphoid carcinoma patients and their family members Anticancer Res, 3: 367-372, 1983.
13. Franke, A. A., Custer, L J., and Cooney, R. V Synthetic carotenoids as internal standards for plasma micronutrient analysis by HPLC. J. Chromatogr. B, 614, 43-57, 1993.
14. Milliken, G A., and Johnson, D. E. Analysis of Messy Data, Volume 1: Designed Experiments. London: Chapman-Hall, 1994.
15. Weitberg, A. B , Weitzman, S. A , Clark, E P., and Stossel, T P. Effects of antioxidants on oxidant-induced sister chromatid exchange formation. J. Clin Invest, 75: 1835-1841, 1985.
16. Stich, H F., and Dunn, B P. Relationship between cellular levels of beta-carotene and sensitivity to genotoxic agents Int. J. Cancer, 38: 713-717, 1986.
17. Cloos, J., Steen, I., Joenje, H., Ko., J-Y., de Vries, N., Steen, I , van de Sterre, L T., Nauta, J. J. P., Snow, G B , and Braakhuis, J. M. Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. Cancer Lett., 74, 161-165, 1993.
18. Cloos, J., Bongers, V., Lubsen, H., Tobi, H., Braakhuis, B J M , and Snow, G. B. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity Cancer Epidemiol. Biomark. Prev, 5: 941-945, 1996.
19. Spitz, M. R., McPherson, R. S., Jiang, H , Hsu, T C , Trizna, Z., Lee, J. J , Lippman, S M., Khuri, F. R , Steffen-Batey, L , Chamberlain, R. M., Schantz, S. P , and Hong, W. K. Correlates of mutagen sensitivity in patients with uper aerodigestive tract cancer. Cancer Epidemiol. Biomark. Prev., 6, 687-692, 1997.
20. Lee, J. J., Trizna, Z., Hsu, T C., Spilz, M. R., and Hong, W K. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay Cancer Epidemiol Biomark Prev., 5, 191-197, 1996.